France· FR:66242285
BISOPROLOL CRISTERS 7,5 mg, comprimé sécable
A bisoprolol product containing hémifumarate de bisoprolol, registered in France by CRISTERS, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Bisoprolol is registered in 19 of 19 countries.
Countries holding a registration under ATC C07AB07 (bisoprolol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Bisoprolol · ATC C07AB07
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bisoprolol costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.18 in Spain to $0.73 in Switzerland — a ×4.1 gap.
- France: $0.20 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bisoprolol · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.73
- IT Italy$0.42
- FR France$0.20
- ES Spain$0.18
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HÉMIFUMARATE DE BISOPROLOL
- Manufacturer
- CRISTERS
- Country
- France (FR)
- ATC code
- C07AB07
- ATC class
- Bisoprolol
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930046173plaquette(s) PVC PVDC aluminium de 30 comprimé(s)EUR 3.88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
360 interactions on record for bisoprolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bisoprolol · interactions on record
360 records
- 11 severe
- 181 moderate
- 20 minor
- 82 info
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
66 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bisoprolol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBisoprolol 7.5mg tabletsHealthcare Pharma Ltd
- SpainBISOPROLOL PENSA 7,5 MG COMPRIMIDOS EFGTowa Pharmaceutical S.A.
- ItalyBISOPROLOLO PENSA PHARMATOWA PHARMACEUTICAL S.P.A.
- IrelandBisoprolol Zentiva 7.5mg tabletsZentiva k.s.
- PolandConaretZentiva, k.s.
- CzechiaBISOCARDBausch Health Ireland Limited, Dublin
- SwedenBisoprolol 2care4 1,25 mg Filmdragerad tablett2care4 ApS
- FinlandBisomerckMerck KGaA
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bisocor, Bisoprolol
- Belgium · Bisoprolol Ab, Bisoprolol Eg
- Bulgaria · Blokbis, Kardoritm
- Cyprus · Bisoprolol Sapiens, Concor
- Czechia · Bisocard, Bisoprolol Medreg
- Germany · Biso Lich, Bisobeta
- Denmark · Bisoprolol Krka, Bisoprolol Medical Valley
- Estonia · Bisoprolol Accord, Bisoprolol Vitabalans
- Spain · Bisoprolol Aurovitas, Bisoprolol Cinfa
- Finland · Bisoproact, Bisoprolol Accord
- United Kingdom (Northern Ireland) · Bisoprolo, Bisoprolol
- Greece · Blocatens, Concor
- Croatia · Bisobel, Byol
- Hungary · Bisoblock, Bisocard
- Ireland · Bisocor, Bisop
- Iceland · Bisbetol, Bisoprolol Medical Valley
- Italy · Bisoprololo Ahcl, Bisoprololo Almus
- Lithuania · Bisoprolol Fumarate Zentiva, Bisoprolol Vitabalans
- Luxembourg · Bisoprolol Eg, Bisoprolol Sandoz
- Latvia · Bisogamma, Bisoprolol Accord
- Malta · Bisoprolol Ipca
- Netherlands · Bisoprolol Fumaraat Pch, Bisoprolol Fumaraat Teva
- Norway · Bisoprolol Sandoz, Bisoprolol Vitabalans
- Poland · Bibloc, Bicardef
- Portugal · Bisoprolol, Bisoprolol Aquizent Zentiva
- Romania · Bisogamma, Bisoprolol Gemax Pharma
- Sweden · Bisomyl Viatris, Bisoprolol Accord
- Slovenia · Borez, Byol
- Slovakia · Bisocard, Bisomerck
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/87a5eea1-a96a-41fb-8b70-edf0be3b7fff GET /v1/drugs/87a5eea1-a96a-41fb-8b70-edf0be3b7fff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66242285",
"date_amm": "2016-02-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "HÉMIFUMARATE DE BISOPROLOL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bisoprolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.